Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.
about
Refocusing of B-cell responses following a single amino acid substitution in an antigenElimination of Schistosoma mansoni Adult Worms by Rhesus Macaques: Basis for a Therapeutic Vaccine?Generation of female genital tract antibody responses by local or central (common) mucosal immunizationSystemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice.Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugatesEnhanced protective antibody responses to PspA after intranasal or subcutaneous injections of PspA genetically fused to granulocyte-macrophage colony-stimulating factor or interleukin-2.Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humansRoute of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretionsCharacterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles.Mucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of miceIntranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in miceM cell-targeted DNA vaccinationRepeated oronasal exposure to lipopolysaccharide induced mucosal IgA responses in periparturient dairy cowsImmunoglobulins in nasal secretions of healthy humans: structural integrity of secretory immunoglobulin A1 (IgA1) and occurrence of neutralizing antibodies to IgA1 proteases of nasal bacteria.A controlled clinical study of the effect of nasal immunization with a Streptococcus mutans antigen alone or incorporated into liposomes on induction of immune responsesAntibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit.Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection.Genital antibody responses in mice after intranasal infection with an attenuated candidate vector strain of Bordetella pertussis.Monoclonal antibody-mediated modulation of the humoral immune response against mucosally applied Streptococcus mutans.Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans.Oral microbial ecology and the role of salivary immunoglobulin AMucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes.Trachea, lung, and tracheobronchial lymph nodes are the major sites where antigen-presenting cells are detected after nasal vaccination of mice with human papillomavirus type 16 virus-like particles.Vaccines against gonorrhea: current status and future challenges.Intranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1Characterization of antigen-presenting cells induced by intragastric immunization with recombinant chimeric immunogens constructed from Streptococcus mutans AgI/II and type I or type II heat-labile enterotoxinsIntranasal immunisation with recombinant Toxoplasma gondii actin partly protects mice against toxoplasmosis.Oral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissues.Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate.Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina.Intranasal immunization of mice with group B streptococcal protein rib and cholera toxin B subunit confers protection against lethal infection.Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protectionImmunogenicity of gonococcal transferrin binding proteins during natural infectionsMucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit B.Stone age diseases and modern AIDS.Identification and characterization of intestinal antigen-presenting cells involved in uptake and processing of a nontoxic recombinant chimeric mucosal immunogen based on cholera toxin using imaging flow cytometry.Tonsillar application of formalin-killed cells of Streptococcus sobrinus reduces experimental dental caries in rabbits.
P2860
Q28367028-37C74374-E032-4444-B0FA-0FDEC351BF4CQ33372341-A223824A-53A0-4981-90FE-09089F637FCDQ33591251-8BCDA063-6E7C-4904-A2B1-BD7D8B18D201Q33592158-487C815F-5467-4FB8-B5DF-1F5FFDBFD49BQ33640085-31D25E9C-2D9C-4EB4-B931-0195961AA149Q33750130-04DD08F0-CB9F-41FE-A1A0-94C4FF8AFD1BQ33752320-3982E289-9694-473D-B9FB-FD9C6806FF29Q33756767-0F65F22D-E722-4EB5-A6EA-662AAAB0A5B3Q33760450-0883CEFC-5740-41A8-B013-7DE1D330B795Q33784891-52DAC3DD-EA18-42AB-BFC8-E6EF358BEA7CQ33788861-FCCC8A65-53F8-438A-9173-6C69C349A00CQ33823755-EBB894D0-35F0-4594-AB91-B0585F360849Q33883543-381CA2F1-CF87-415B-A46C-43E32AE0A522Q33930880-C44668FC-B2CF-490A-AA38-D34C94D76D73Q33952563-8E7F0AEC-D00E-4878-AFBF-6BB57203BB5BQ33998093-09B2DB2F-A7F0-44E0-82AC-DACFC0C11C87Q34000204-760308CF-6B21-4907-BA91-0AB42C56F16EQ34001107-2A30ECE8-3D6A-40E2-80D7-34EC9AC950D5Q34001604-35EA612F-2783-4B1C-9CF6-456F9245B602Q34003167-90F10CE0-071D-40FF-AE3F-50A469F349DEQ34003768-5FA47F2B-3D3B-4CC4-97D9-4DA7D13AD3E9Q34006720-C21CA240-E51C-4150-9C6D-5E94851093DCQ34009698-BC34C784-FFA9-4462-9C32-82864695D661Q34009973-60494FD1-F5D3-4D9F-98B7-D6F33BD53338Q34145098-242C87B0-9EDF-41D1-B381-F5E3E89951CDQ34353473-AAEB9E48-A18D-4999-9B44-19E745C33DA9Q34369729-6E7EF75F-A6D4-4335-99D0-EBE7CAF3ACDBQ34434903-E01623B3-1F23-4DB8-8E3F-57C95A40EFBEQ34972133-FECF3956-78C3-4A7C-9E9A-160C6B0AA08DQ35080048-95D76BB3-1E27-47E5-8CD1-B320EF279EC5Q35543988-0AAB6F5C-4437-447C-9354-B67BA3E68AF5Q35546011-ED7FAC89-0175-447B-9275-E40BBCAEA90BQ35550710-32839754-79EA-492E-93D8-CF5CFC12B797Q35550898-C69F6C6A-54ED-4B37-8CCA-023A07E116CFQ36095558-1B12EEE6-A3F6-4265-AF52-2B4C2769153EQ36228374-65D3786F-0296-4D7C-8F41-ED83DAD0ACD5Q36464264-2BCC7D16-6C3D-4D15-BB6D-7716D909CF14Q36865422-E2A39BA3-F691-4A75-BD7E-83A48C720666Q37544969-8609C767-D337-47C0-9FA6-FB33C0531AFEQ39509403-C03C7A49-4665-422C-A129-9946375B3F71
P2860
Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.
description
1996 nî lūn-bûn
@nan
1996 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Salivary, nasal, genital, and ...... d the Cholera toxin B subunit.
@ast
Salivary, nasal, genital, and ...... d the Cholera toxin B subunit.
@en
type
label
Salivary, nasal, genital, and ...... d the Cholera toxin B subunit.
@ast
Salivary, nasal, genital, and ...... d the Cholera toxin B subunit.
@en
prefLabel
Salivary, nasal, genital, and ...... d the Cholera toxin B subunit.
@ast
Salivary, nasal, genital, and ...... d the Cholera toxin B subunit.
@en
P2093
P2860
P921
P1476
Salivary, nasal, genital, and ...... d the Cholera toxin B subunit.
@en
P2093
G J Sibert
J Mestecky
M Michalek S
M W Russell
Z Moldoveanu
P2860
P304
P407
P577
1996-04-01T00:00:00Z